These findings emphasize that the co-culture of MTAP-deleted cells with MTAP-intact cells negates the selective vulnerability caused by MTAP deletion, thereby indicating that MTAP-deletion sensitivity in a heterogeneous human GBM tumor may be attenuated by the presence of stroma in the tumor microenvironment. The gene discussed is MTAP; the disease is glioblastoma.